Cimmino et al. documented a tumor-suppressor role of TET1 and found alternative mechanisms of TET1 inactivation in human B-cell non-Hodgkin lymphomas (NHL) [33]. The gene discussed is TET1; the disease is B-cell non-Hodgkin lymphoma.